Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 01, 2019
Source ID
10.1016/j.isci.2019.06.001

Entities

People

  • Narendra Wajapeyee
  • Parmanand Malvi
  • Radoslav Janostiak

Organizations

  • American Cancer Society
  • National Institutes of Health
  • United States Department of Defense